Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes

被引:133
作者
Salmon, P
Oberholzer, J
Occhiodoro, T
Morel, P
Lou, JN
Trono, D
机构
[1] CMU, Dept Genet & Microbiol, Fac Med, CH-1211 Geneva 4, Switzerland
[2] CMU, Fac Med, Div Surg Res, CH-1211 Geneva, Switzerland
关键词
HIV vectors; lentiviral vectors; conditional immortalization; reversible immortalization; gene therapy; gene transfer; LoxP-Cre; SV40 large T; Bmi-1; telomerase; pancreatic beta cell; insulin;
D O I
10.1006/mthe.2000.0141
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We exploited the ability of lentiviral vectors to govern the stable transduction of cells irrespective of their cycling status to induce the reversible immortalization of human primary cells. First, bicistronic HIV-derived lentiviral vectors expressing GFP- and the HSV1 thymidine kinase and containing the LoxP sequence in their LTR (HLox) were used to transduce HeLa cells. Cre expression led to efficient proviral deletion, and unexcised cells could be eliminated by ganciclovir treatment. A human liver biopsy was then exposed to a combination of HLox vectors that harbored either the SV40 large T (TAg) or the human telomerase (hTERT) DNAs in place of GFP. This led to the isolation of liver sinusoidal endothelial cell (LSEC) clones that exhibited an immortalized phenotype while retaining most of the features of primary hLSEC. Complete growth arrest of these cells was observed in 2 days of Cre expression, and the resulting stationary culture could be kept for at least 2 weeks. Transduction of human adult pancreatic islets with HLox vectors coding for Tag and Bmi-1also induced the proliferation of insulin-positive cells. These results indicate that lentivectors can be used to mediate the reversible immortalization of primary nondividing cells and should allow for the production of large supplies of a wide variety of human cells for both therapeutic and research purposes.
引用
收藏
页码:404 / 414
页数:11
相关论文
共 52 条
[1]   EXCISION OF SPECIFIC DNA-SEQUENCES FROM INTEGRATED RETROVIRAL VECTORS VIA SITE-SPECIFIC RECOMBINATION [J].
BERGEMANN, J ;
KUHLCKE, K ;
FEHSE, B ;
WOLFRAM, IR ;
LOTHER, H .
NUCLEIC ACIDS RESEARCH, 1995, 23 (21) :4451-4456
[2]   Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene [J].
Berghella, L ;
De Angelis, L ;
Coletta, M ;
Berarducci, B ;
Sonnino, C ;
Salvatori, G ;
Anthonissen, C ;
Cooper, R ;
Butler-Browne, GS ;
Mouly, V ;
Ferrari, G ;
Mavilio, F ;
Cossu, G .
HUMAN GENE THERAPY, 1999, 10 (10) :1607-1617
[3]   Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture [J].
Bhatia, M ;
Bonnet, D ;
Kapp, U ;
Wang, JCY ;
Murdoch, B ;
Dick, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (04) :619-624
[4]  
Blomer U, 1997, J VIROL, V71, P6641
[5]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[6]   Essential role for oncogenic Ras in tumour maintenance [J].
Chin, L ;
Tam, A ;
Pomerantz, J ;
Wong, M ;
Holash, J ;
Bardeesy, N ;
Shen, Q ;
O'Hagan, R ;
Pantginis, J ;
Zhou, H ;
Horner, JW ;
Cordon-Cardo, C ;
Yancopoulos, GD ;
DePinho, RA .
NATURE, 1999, 400 (6743) :468-472
[7]   REQUIREMENT FOR THE SIMIAN VIRUS-40 SMALL TUMOR-ANTIGEN IN TUMORIGENESIS IN TRANSGENIC MICE [J].
CHOI, YW ;
LEE, I ;
ROSS, SR .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (08) :3382-3390
[9]   Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site [J].
Choulika, A ;
Guyot, V ;
Nicolas, JF .
JOURNAL OF VIROLOGY, 1996, 70 (03) :1792-1798
[10]   Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors [J].
Curran, MA ;
Kaiser, SM ;
Achacoso, PL ;
Nolan, GP .
MOLECULAR THERAPY, 2000, 1 (01) :31-38